Dec 31, 2020

Entrada Therapeutics Q4 2020 Earnings Report

EPS
-$53.9
Cash and Equivalents
$39M
Free Cash Flow
-$8.07M
Total Assets
$43.5M

Entrada Therapeutics

Entrada Therapeutics